Article
Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial
(2017)
Disciplines
Publication Date
January 1, 2017
Citation Information
Philip J. Mease, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, et al.. "Secukinumab provides sustained improvements in the signs and symptoms of active psoriatic arthritis: 3-year efficacy and safety results from phase 3 future 1 trial" (2017) Available at: http://works.bepress.com/philip-mease/71/